Goodwin’s Life Sciences Capital Markets team advised BridgeBio (BBIO) Pharma on its offering of 1.75% Convertible Senior Notes due 2031. The offering priced at $500M, plus the full exercise of ...

Prior to December 2, 2030, the notes will be convertible only upon satisfaction of certain conditions and during certain periods. Thereafter, the notes will be convertible at any time until the ...

BridgeBio Pharma (NASDAQ:BBIO) said on Monday that it intends to offer $500M aggregate principal amount of convertible senior notes due 2031 in a private offering. In connection with the offering ...

Investing.com -- Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) dipped 3% in after-hours trading on Monday following the company's announcement of a proposed offering of convertible senior notes ...

Video game retailer GameStop has announced another plan to dilute shareholders with a convertible debt offering worth up to $1.5 billion.

Jaguar Health, Inc. (NASDAQ:JAGX) (”Jaguar” or “the Company”), today announced the closing of its previously announced private placement.

On or after March 6, 2028 and on or before the 41st scheduled trading day immediately before the maturity date of the notes, the Company may redeem for cash all or any portion of the notes ...